The Massachusetts General Hospital has a longstanding tradition of excellence in clinical and basic investigations in Reproductive Endocrinology. This tradition remains quite alive to date and is currently embodied by a group of actively-collaborating investigators whose research in reproduction covers a spectrum from basic molecular biology to clinical investigation. Four individual Units (Reproductive Endocrine, General Endocrine, Thyroid, and Developmental Biology) represent the center of these activities. Each has developed a critical mass of staff and an increasing network of informal collaborations over the past decade that capitalizes upon their individual strengths. In recognition of this growing interdependence, we propose to formalize these interactions with the establishment of a Reproductive Endocrine Sciences Center via the P30 Center mechanism consisting of 6 Core facilities: Administrative, Molecular Biology, Peptide Synthesis/Protein Sequencing, Histology/Organ Culture, Cell Culture, and Radioimmunoassay. The Cores will serve 15 investigators with 20 grants from 4 separate departments. This Center structure will dramatically widen the scope of scientific interactions among the center investigators and should translate to unusually swift transfer of basic advances into the clinical arena in this setting. The investigators responsible for the Core facilities are each mid-career scientists with considerable institutional stability; are recognized leaders in the areas of their proposed Core responsibilities; employ state-of-the-art technologies; and provide the Center both competent supervision and considerable economies of scale and improved cost effectiveness. The institutional setting for this proposal is unique in its traditions of commitment to basic and clinical biomedical-investigations, its current composition of productive investigators, and its commitment to the present proposal. The proposed Reproductive Endocrine Sciences Center therefore offers the proper constellation of excellence, efficiency, and collaborative science to result in a marked augmentation in research in Reproductive Endocrinology in this setting, given support by the establishment of a P30 Center.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Center Core Grants (P30)
Project #
5P30HD028138-02
Application #
3103112
Study Section
Population Research Committee (HDPR)
Project Start
1991-05-01
Project End
1996-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Crowley, William F; Balasubramanian, Ravi (2017) MicroRNA-7a2 suppression causes hypogonadotropism and uncovers signaling pathways in gonadotropes. J Clin Invest 127:796-797
Chan, Yee-Ming; Lippincott, Margaret F; Butler, James P et al. (2014) Exogenous kisspeptin administration as a probe of GnRH neuronal function in patients with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 99:E2762-71
Costa-Barbosa, Flavia Amanda; Balasubramanian, Ravikumar; Keefe, Kimberly W et al. (2013) Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab 98:E943-53
Bianco, Suzy D C; Kaiser, Ursula B (2009) The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol 5:569-76
Adams, Judith M; Taylor, Ann E; Crowley Jr, William F et al. (2004) Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 89:4343-50
Gill, S; Taylor, A E; Martin, K A et al. (2001) Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. J Clin Endocrinol Metab 86:2428-36
Welt, C K; Schneyer, A L (2001) Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab 86:330-6
Hayes, F J; Pitteloud, N; DeCruz, S et al. (2001) Importance of inhibin B in the regulation of FSH secretion in the human male. J Clin Endocrinol Metab 86:5541-6
Welt, C K; Smith, Z A; Pauler, D K et al. (2001) Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development. J Clin Endocrinol Metab 86:2531-7
Wang, Q; Keutmann, H T; Schneyer, A L et al. (2000) Analysis of human follistatin structure: identification of two discontinuous N-terminal sequences coding for activin A binding and structural consequences of activin binding to native proteins. Endocrinology 141:3183-93

Showing the most recent 10 out of 54 publications